주식/증권
➡️ 중립
관련 뉴스
NeoGenomics anticipates $802M-$806M 2026 revenue as it targets mid-20% NGS growth and adjusts pharma expectations
07/29/2026
Omnicom targets 4.5%-5% 2026 organic growth while advancing $900M synergies and completing $5B buyback by Q1 2027
07/29/2026
Corning outlines Springboard 20-30-40 plan with 19% sales CAGR and guides Q3 sales to $4.9B-$5.0B
07/29/2026
2 Reasons to Sell EFX and 1 Stock to Buy Instead
07/29/2026